Skip to main content
SpringerLink
Log in

Single-unit buccal midazolam can save costs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The study was funded by Veriton Pharma.

Reference

  • Ludwig C, et al. Buccal Midazolam Solution for the Management of Prolonged Acute Convulsive Seizures: A Cost Analysis. PharmacoEconomics-Open : 11 Jul 2019. Available from: URL: https://doi.org/10.1007/s41669-019-0164-x

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Single-unit buccal midazolam can save costs. PharmacoEcon Outcomes News 833, 29 (2019). https://doi.org/10.1007/s40274-019-6093-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6093-1

Search

Navigation